Adipose-Derived Stem/Stromal Cells in Regenerative Medicine
January 2016
in “
Springer eBooks
”
Studysummary This review discusses the potential of adipose-derived stem cells for regenerative medicine, highlighting their ability to differentiate, secrete factors, and modulate the immune response, but reports no new findings.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The document from 2016 highlights the potential of adipose-derived stem/stromal cells (ASCs) in regenerative medicine, noting their multipotency and ability to differentiate into various cell lineages, including those relevant for treating alopecia, liver damage, bone defects, and nerve injuries. It reports that 168 clinical trials involving ASCs were registered, with 38 completed, and discusses various preconditioning strategies to enhance ASCs' therapeutic effects. The document also stresses the importance of Good Manufacturing Practice standards and the need for further research on the safety, effectiveness, and long-term outcomes of ASC therapies.
